M4MM
Curaleaf Reports Q3 2026 Financial and Operational Results
STAMFORD – Curaleaf Holdings Inc. posted third-quarter 2026 net revenue of $352.7 million with gains across both its domestic and international segments. Revenue grew 11% YoY and roughly 4% sequentially, extending three straight quarters of ...
Analysis: Higher THC Potency Doesn’t Always Correspond with More Pronounced Mood-Altering Effects
Melbourne, Australia: Doubling THC potency doesn’t necessarily lead to a corresponding increase in cannabis’ mood-altering effects, according to a review of 40 human studies published in the journal Neuroscience & Biobehavioral Reviews. Researchers from Australia, ...
Big Alcohol. Big Tobacco. What About Big Marijuana?
By Mark Collins | HCN Opinion When Democratic Texas U.S. Senate candidate James Talarico identified Big Alcohol and Big Tobacco as beneficiaries of restrictions on hemp-derived THC, he raised an important question: Who profits when ...
Curaleaf Reports Q3 2026 Financial and Operational Results
STAMFORD – Curaleaf Holdings Inc. posted third-quarter 2026 net revenue of $352.7 million with gains across both its domestic and international segments. Revenue grew 11% YoY and roughly 4% sequentially, extending three straight quarters of ...
Analysis: Higher THC Potency Doesn’t Always Correspond with More Pronounced Mood-Altering Effects
Melbourne, Australia: Doubling THC potency doesn’t necessarily lead to a corresponding increase in cannabis’ mood-altering effects, according to a review of 40 human studies published in the journal Neuroscience & Biobehavioral Reviews. Researchers from Australia, ...
Big Alcohol. Big Tobacco. What About Big Marijuana?
By Mark Collins | HCN Opinion When Democratic Texas U.S. Senate candidate James Talarico identified Big Alcohol and Big Tobacco as beneficiaries of restrictions on hemp-derived THC, he raised an important question: Who profits when ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – Federal regulators drew a firm line around medical Сannabis, a hostile bid for Aurora turned more personal, and Q3 2026 earnings showed which operators convert retail traffic into cash. Capital deployment remains ...
Curaleaf Reports Q3 2026 Financial and Operational Results
STAMFORD – Curaleaf Holdings Inc. posted third-quarter 2026 net revenue of $352.7 million with gains across both its domestic and international segments. Revenue grew 11% YoY and roughly 4% sequentially, extending three straight quarters of ...
Analysis: Higher THC Potency Doesn’t Always Correspond with More Pronounced Mood-Altering Effects
Melbourne, Australia: Doubling THC potency doesn’t necessarily lead to a corresponding increase in cannabis’ mood-altering effects, according to a review of 40 human studies published in the journal Neuroscience & Biobehavioral Reviews. Researchers from Australia, ...
Big Alcohol. Big Tobacco. What About Big Marijuana?
By Mark Collins | HCN Opinion When Democratic Texas U.S. Senate candidate James Talarico identified Big Alcohol and Big Tobacco as beneficiaries of restrictions on hemp-derived THC, he raised an important question: Who profits when ...
Curaleaf Reports Q3 2026 Financial and Operational Results
STAMFORD – Curaleaf Holdings Inc. posted third-quarter 2026 net revenue of $352.7 million with gains across both its domestic and international segments. Revenue grew 11% YoY and roughly 4% sequentially, extending three straight quarters of ...
Analysis: Higher THC Potency Doesn’t Always Correspond with More Pronounced Mood-Altering Effects
Melbourne, Australia: Doubling THC potency doesn’t necessarily lead to a corresponding increase in cannabis’ mood-altering effects, according to a review of 40 human studies published in the journal Neuroscience & Biobehavioral Reviews. Researchers from Australia, ...
Big Alcohol. Big Tobacco. What About Big Marijuana?
By Mark Collins | HCN Opinion When Democratic Texas U.S. Senate candidate James Talarico identified Big Alcohol and Big Tobacco as beneficiaries of restrictions on hemp-derived THC, he raised an important question: Who profits when ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – Federal regulators drew a firm line around medical Сannabis, a hostile bid for Aurora turned more personal, and Q3 2026 earnings showed which operators convert retail traffic into cash. Capital deployment remains ...
DEA Bars Dual-Purpose Dispensaries From Federal Medical Cannabis Registration
WASHINGTON – In April, followed by Trump administration's rescheduling order, the U.S. Department of Justice announced that the DEA had granted federal registrations to more than 900 state-licensed medical Cannabis dispensaries in Alabama, Florida, Mississippi, ...
Cannabis Deals Multiply and Shrink in Q3 2026, Viridian Finds
LOS ANGELES – The Viridian Cannabis Deal Tracker counted 74 transactions in the third quarter: 28 in M&A, 27 in equity and 19 in debt. That is the most in any quarter since early 2023 ...
AJNA Biosciences Files for DEA Authorization to Grow Cannabis Under FDA Drug Framework
LITTLETON – AJNA Biosciences, a botanical drug development company, applied to the DEA for registration as a bulk manufacturer of Schedule I controlled substances. The filing, made available for public inspection on 30 October and ...
Optimi Goes Down Under with New Australian Subsidiary
VANCOUVER / SYDNEY – Optimi Health Corp., a commercial-stage pharmaceutical developer and manufacturer of regulated psychedelic drug products, announced the establishment of Optimi Australia Pty Ltd, a wholly owned subsidiary responsible for distribution and business ...
Cannabis Buyers Are Price-Sensitive, Now The Federal Data Proves It
LOS ANGELES – The study, published this month in the peer-reviewed journal Addiction, was conducted by researchers at the University of California San Diego and received funding from the National Institute on Drug Abuse (NIDA) ...
Argent BioPharma Licenses Proprietary Cannabis Genetics in Global Thai Phytomed Agreement
LONDON / PERTH – Argent BioPharma Ltd. has signed a decade-long exclusive worldwide licensing agreement with Thai Phytomed International (TPI), covering four proprietary Cannabis genotypes developed within the Argent group over several years. Under the ...
Jushi Reports Q3 2026 Financial Results
BOCA RATON – Jushi Holdings Inc. released its third-quarter 2026 financial results, reporting $70.5 million in revenue, a 7% YoY gain driven by record wholesale volume and retail growth across several key states, even as ...
Verano Reports Q3 2026 Financial Results
CHICAGO – Verano Holdings Corp. reported $212.4 million in third-quarter revenue, a 5% increase YoY. The figure came in modestly below analyst estimates of $216.4 million and trailed the $217.9 million posted last quarter, but ...
How to Survive MJBizCon: Parties, Meetings and Making It Worth the Trip
LAS VEGAS- An HCN guide to better connections, good parties and making the trip pay off long after Vegas Every year, sensible cannabis professionals travel to Las Vegas carrying three business objectives, two phone chargers ...
Could California Become Germany’s Next Recognizable Cannabis Origin?
LOS ANGELES- California’s products and ideas have been crossing the Atlantic for decades. Germans watch Hollywood films, listen to West Coast hip-hop, drink Californian wine and use technology developed in Silicon Valley. The cultural connection ...
Germany’s Medical Cannabis Market Is Becoming a Global Supply Opportunity
LOS ANGELES- Germany’s medical Cannabis market offers North American producers an opportunity that exists today: supplying prescription products through an established pharmaceutical channel. Its significance lies in the combination of rising imports, regulated distribution and ...
